Explore All 3110 Add-on Acquisition Life Science Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | November 12, 2021 |
| Target | Advanced Diagnostic Laboratory |
| Sector | Life Science |
| Buyer(s) | EKF Diagnostics |
| Deal Type | Add-on Acquisition |
FILTER BY
| Category | Company |
|---|---|
| Founded | 1990 |
| Sector | Medical Products |
| Employees | 303 |
| Revenue | 50M GBP (2024) |
EKF Diagnostics is an integrated medical diagnostics business. EKF designs and manufactures diagnostic equipment for use within point-of-care settings. EKF Diagnostics is also a manufacturer of liquid reagents used in central laboratory analysers and also sells a number of benchtop analyzers. EKF Diagnostics was incorporated in 1990 and is based in Cardiff, the United Kingdom.
| Deal Context for Buyer | # |
|---|---|
| Overall | 3 of 3 |
| Sector: Life Science | 1 of 1 |
| Type: Add-on Acquisition | 3 of 3 |
| State: Texas | 1 of 1 |
| Country: United States | 2 of 2 |
| Year: 2021 | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2014-03-20 |
Selah Genomics
Greenville, South Carolina, United States Selah Genomics is a clinical diagnostic company that is rapidly growing at the cutting edge of molecular analysis and next generation sequencing (NGS), and is emerging as a leader in the development of personalized medicine. |
Buy | $70M |
